v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Shares reserved under the Sales Agreement
Common Stock
Common Stock
Shares reserved under the Sales Agreement
Additional Paid-in Capital
Additional Paid-in Capital
Shares reserved under the Sales Agreement
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Mar. 31, 2024     27,029,731            
Beginning balance at Mar. 31, 2024 $ 114,286   $ 27   $ 474,441   $ (3,968) $ 0 $ (356,214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation expense 4,315       4,315        
Sale of common stock pursuant to 2019 Employee Stock Purchase Plan (in shares)     74,804            
Sale of common stock pursuant to 2019 Employee Stock Purchase Plan 201       201        
Issuance of common stock under Open Market Sale Agreement, net of issuance costs (in shares)       1,108,587          
Issuance of common stock under Open Market Sale Agreement, net of issuance costs   $ 3,000   $ 1   $ 2,999      
Issuance of common stock upon exercise of Pre-Funded Warrants (in shares)     788,359            
Issuance of common stock upon exercise of Pre-Funded Warrants 1   $ 1            
Net loss (51,418)               (51,418)
Ending balance (in shares) at Mar. 31, 2025     29,001,481            
Ending balance at Mar. 31, 2025 70,390   $ 29   481,956   (3,968) 5 (407,632)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation expense 3,997       3,997        
Sale of common stock pursuant to 2019 Employee Stock Purchase Plan (in shares)     217,784            
Sale of common stock pursuant to 2019 Employee Stock Purchase Plan 231       231        
Unrealized loss on marketable securities available-for-sale, net (7)             (7)  
Issuance of common stock under Open Market Sale Agreement, net of issuance costs (in shares)     10,403,244            
Issuance of common stock under Open Market Sale Agreement, net of issuance costs $ 30,586   $ 11   30,575        
Issuance of common stock upon exercise of stock options (in shares) 1,831,827   2,330            
Issuance of common stock upon exercise of stock options $ 8       8        
Net loss (69,685)               (69,685)
Ending balance (in shares) at Mar. 31, 2026     39,624,839            
Ending balance at Mar. 31, 2026 $ 35,520   $ 40   $ 516,767   $ (3,968) $ (2) $ (477,317)